GLP-1 & Tirzepatide: Powerful Health Benefits Explained #shorts
23 Apr 2026 · 1 min

0:36
In this brief YouTube short, Dr. Tabatha Barber explains that GLP‑1 agonists and tirzepatide can be effective at much lower doses than typical prescribing guidelines—sometimes as low as 10‑25% of the standard starting dose (e.g., 0.5–1 mg of tirzepatide versus the usual 2.5 mg). She highlights two key health benefits: strong anti‑inflammatory effects and a notable reduction in cardiovascular risk, specifically a roughly 15% lower chance of heart attack, which she emphasizes as especially important for women, the leading demographic affected by heart disease.










